Solid Biosciences (SLDB) Earnings Analysis
Solid Biosciences (SLDB) next reports earnings on 2026-08-11, consensus EPS -0.43 USD. Last quarter (2026-03-19) it beat with EPS -0.5 USD vs -0.51 USD est (+2%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -4.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SLDB next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.43 USD |
| Revenue estimate | n/a |
SLDB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-19 | -0.5 USD | -0.51 USD | +2% | Beat |
| 2025-11-03 | -0.48 USD | -0.42 USD | -14.3% | Miss |
| 2025-08-12 | -0.42 USD | -0.51 USD | +17.6% | Beat |
| 2025-05-15 | -0.59 USD | -0.53 USD | -11.3% | Miss |
| 2025-03-06 | -0.89 USD | -0.79 USD | -12.7% | Miss |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
SLDB valuation and analyst view
| Trailing P/E | -4.15 |
|---|---|
| Trailing EPS | -1.74645 USD |
| Price / book | 2.38 |
| Dividend yield | 0.00% |
| Market cap | 0.63B |
| Analyst consensus | Buy (16 buy / 5 hold / 0 sell) |
| Avg price target | 17 USD |
Related research pages
Frequently asked questions
When is Solid Biosciences (SLDB)'s next earnings date?
Solid Biosciences is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.43 USD.
Did SLDB beat earnings last quarter?
In its 2026-03-19 report, SLDB posted EPS of -0.5 USD versus a -0.51 USD estimate — a beat of 2%.
What is SLDB's earnings track record?
Over the last 5 reported quarters with consensus data, SLDB beat estimates 2 times (40%).
What is SLDB's current P/E ratio and EPS?
SLDB trades at a trailing P/E of -4.15 on trailing EPS of -1.7464479413492187 USD.
What do analysts rate SLDB?
Analyst consensus is "Buy" across 21 ratings (0 strong buy, 16 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 17 USD.